Erdafitinib,Vinflunine,Docetaxel,Pembrolizumab
Janssen,pierre fabre,Merck
['erdafitinib', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'gucsm']
#asco23: thor results indicate mos, pfs &amp; orr are all significantly improved w/ erdafitinib compared w/ chemo, demonstrating a 36% risk reduction in death in pts w/uc: #ascodailynews #gucsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.